Progress in Addressing Hyperlipidemia in the Primary Prevention Setting
A Q&A with Steven E. Nissen, M.D., M.A.C.C.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Sponsored: The Teva Biosimilars Trend Report
2
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
3
The 6-Year Cure Threshold: Redefining Cure for Colon Cancer Survivors
4
WHO Global Report on Antimicrobial Resistance Sheds Light on Growing Threat
5
